1. 1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study. (September 2015) Authors: Zacchia, A.; Gullo, G.; Parker, I.; De Giorgi, A.; Fennelly, D.; Zanoni, D.; Walshe, J.; Defrein, A.M.; Quinn, C.; Silva, N.; O' Donovan, N.; Ballot, J.; Mc Dermott, E.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx). (February 2017) Authors: Gullo, G.; Walsh, N.; Zacchia, A.; Hammond, L.; Fennelly, D.; Walshe, J.; O'Mahony, K.; Maltese, M.; Crown, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer. Issue 6 (24th July 2018) Authors: Ryan, É. J.; Creavin, B.; Khaw, Y. L.; Kelly, M. E.; Mohan, H. M.; Geraghty, R.; Ryan, E. J.; Kennelly, R.; Hanly, A.; Martin, S. T.; Fennelly, D.; McDermott, R.; Gibbons, D.; O'Connell, P. R; Sheahan, K.; Winter, D. C. Journal: BJS open Issue: Volume 2:Issue 6(2018) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exploring the feasibility of a supportive care intervention for patients undergoing neo-adjuvant chemotherapy for pancreatic cancer: The FEED study (a fish oil supplement, pancreatic enzyme supplement, exercise advice and individualised dietary counselling). (2020) Authors: Griffin, O.; Duggan, S.; Fennelly, D.; McDermott, R.; Geoghegan, J.; Conlon, K. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer. Issue 11 (November 2016) Authors: Mohan, H.M.; Ryan, E.; Balasubramanian, I.; Kennelly, R.; Geraghty, R.; Sclafani, F.; Fennelly, D.; McDermott, R.; Ryan, E.J.; O'Donoghue, D.; Hyland, J.M.P.; Martin, S.T.; O'Connell, P.R.; Gibbons, D.; Winter, Des; Sheahan, K. Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PROLONGED SURVIVAL IN TWO CASES OF CARCINOMA OF THE FALLOPIAN TUBE PRESENTING AFTER HYSTERECTOMY: CASE REPORT. Issue 1 (1st March 2003) Authors: Alarab, M.; Fennelly, D.; Foley, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Use of contrast-enhanced Magnetic Resonance Imaging (MRI) to predict pathological response after trastuzumab (T) – based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (HER2BrCa). (April 2018) Authors: Flynn, C.; Gullo, G.; Walshe, J.; O'doherty, A.; Fennelly, D.; Mcdermott, E.; Crown, J. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗